An Investigation of ReNu Knee Injection: Monitoring the Response of Knee Function and Pain in Patients With Osteoarthritis

Trial Profile

An Investigation of ReNu Knee Injection: Monitoring the Response of Knee Function and Pain in Patients With Osteoarthritis

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 31 Aug 2017

At a glance

  • Drugs Amniotic cell therapy-NuCel (Primary)
  • Indications Osteoarthritis
  • Focus Therapeutic Use
  • Sponsors Nutech Medical
  • Most Recent Events

    • 24 Aug 2017 Status changed from recruiting to active, no longer recruiting.
    • 11 Aug 2016 Planned number of patients changed from 150 to 200.
    • 11 Aug 2016 Planned End Date changed from 1 Mar 2017 to 1 Mar 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top